Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

November 30, 2014

Conditions

Allergic Asthma

Interventions

DEVICE

IgE adsorber

Two plasma volumes of each patient in the apheresis group will be treated per session

Trial Locations (1)

Medical University Vienna, Vienna

All Listed Sponsors

lead

Fresenius Medical Care Deutschland GmbH

INDUSTRY

NCT02096237 - Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study) | Biotech Hunter | Biotech Hunter